FDA EIR - Toshoku America, Inc. - March 07, 2025

A U.S. Food and Drug Administration (FDA) inspection of Toshoku America, Inc., a subsidiary of Cargill Corporation, was conducted on March 7, 2025. The inspection, an initial review under the Foreign Supplier Verification Program (FSVP) for human foods, focused on the company's compliance with regulations governing imported food safety. Toshoku America, Inc., located in Irvine, CA, imports various food products including honey, wheat flour, and refined sugar.

The overall outcome of the inspection was "No Action Indicated" (NAI), meaning no significant deficiencies requiring regulatory action were found in the company's FSVP. The firm's FSVP records were deemed adequate, and its foreign supplier verification activities were assessed as providing assurance that hazards were significantly minimized or prevented. However, during the inspection, the company's President declined to provide customer lists and sales invoices, asserting these documents contained trade secrets. Despite these refusals, the comprehensive review of their FSVP documentation for imported foods resulted in the NAI status. Consequently, no specific regulatory actions or further requirements were mandated for Toshoku America, Inc. by the FDA following this inspection.